JNJ vaccine linked to new side effect: CDC
For this year the company, based in New Brunswick revenue will be around 94.47 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 82.58 billion USD.
Historical revenues and results Johnson & Johnson plus estimates 2021
The analysts expect for 2021 a net profit of 25.79 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 9.67 USD. Based on this the price/earnings-ratio is 17.81.
Per share the analysts expect a dividend of 4.19 USD per share. Johnson & Johnson 's dividend yield thus equals 2.43 percent. The average dividend yield of the health care companies is a limited 1.45 percent.
Newest target prices around 177 USD
Credit Suisse , ABN AMRO and KBC Securities recently provided recommendations for the stock.Based on the current number of outstanding shares Johnson & Johnson 's market capitalization 453.27 billion USD. 20
Historical stock prices Johnson & Johnson past 10 years
On Thursday the stock closed at 172.18 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
